Safety and Pharmacokinetics of GH002 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

November 29, 2023

Study Completion Date

November 29, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

5 Methoxy N,N Dimethyltryptamine

GH002 administered via i.v. bolus injection(s)

DRUG

Placebo

GH002 placebo administered via i.v. bolus injection

Trial Locations (1)

GH Research Clinical Trial Site, Groningen

All Listed Sponsors

lead

GH Research Ireland Limited

INDUSTRY